ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 180 filers reported holding ASCENDIS PHARMA A/S in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,811 | +6.3% | 115,454 | +1.3% | 0.03% | +13.0% |
| Q2 2023 | $10,170 | -25.4% | 113,952 | -10.4% | 0.02% | -30.3% |
| Q1 2023 | $13,629 | -10.9% | 127,116 | +1.5% | 0.03% | -17.5% |
| Q4 2022 | $15,290 | -99.9% | 125,198 | +1.8% | 0.04% | +14.3% |
| Q3 2022 | $12,694,000 | +0.4% | 122,928 | -9.6% | 0.04% | +2.9% |
| Q2 2022 | $12,640,000 | -26.3% | 135,979 | -7.0% | 0.03% | 0.0% |
| Q1 2022 | $17,162,000 | -14.7% | 146,231 | -2.2% | 0.03% | -12.8% |
| Q4 2021 | $20,120,000 | -18.2% | 149,557 | -3.1% | 0.04% | -22.0% |
| Q3 2021 | $24,604,000 | +4.1% | 154,359 | -14.1% | 0.05% | +4.2% |
| Q2 2021 | $23,626,000 | +10.5% | 179,603 | +8.2% | 0.05% | +2.1% |
| Q1 2021 | $21,389,000 | – | 165,961 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |